Elevated salivary endothelin levels in oral cancer patients-A pilot study

Victoria Pickering, Richard C K Jordan, Brian Schmidt

Research output: Contribution to journalArticle

Abstract

The analysis of saliva has been proposed as a potentially rapid, non-invasive method to monitor and diagnose patients with oral disease. In this study we measured salivary endothelin-1 (ET-1) levels in patients diagnosed with oral squamous cell carcinoma (SCC) prior to treatment. We demonstrate significantly elevated salivary ET-1 levels in the oral SCC group (4.37 ± 1.35 pg/ml), relative to the control group (1.16 ± 0.29 pg/ml). ET-1 and ET-1 mRNA were also measured in oral SCC tissue specimens and compared to normal oral epithelial controls. The concentration of ET-1 in the oral SCC specimens was 17.87 ± 4.0 pg/ml and in the normal epithelial controls the concentration of ET-1 was 5.43 ± 2.5 pg/ml. ET-1 mRNA was significantly overexpressed in 80% (8/10) of the oral SCC specimens. Our results demonstrate the potential utility of salivary analysis for ET-1 levels to monitor patients at risk for oral SCC.

Original languageEnglish (US)
Pages (from-to)37-41
Number of pages5
JournalOral Oncology
Volume43
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Mouth Neoplasms
Endothelins
Endothelin-1
Squamous Cell Carcinoma
Mouth Diseases
Messenger RNA
Saliva
Control Groups

Keywords

  • Endothelin
  • ET-1
  • Oral cancer
  • Oral squamous cell carcinoma
  • Saliva

ASJC Scopus subject areas

  • Oncology

Cite this

Elevated salivary endothelin levels in oral cancer patients-A pilot study. / Pickering, Victoria; Jordan, Richard C K; Schmidt, Brian.

In: Oral Oncology, Vol. 43, No. 1, 01.2007, p. 37-41.

Research output: Contribution to journalArticle

Pickering, Victoria ; Jordan, Richard C K ; Schmidt, Brian. / Elevated salivary endothelin levels in oral cancer patients-A pilot study. In: Oral Oncology. 2007 ; Vol. 43, No. 1. pp. 37-41.
@article{b3bb2d9f2a1647ccab3cd393121c133a,
title = "Elevated salivary endothelin levels in oral cancer patients-A pilot study",
abstract = "The analysis of saliva has been proposed as a potentially rapid, non-invasive method to monitor and diagnose patients with oral disease. In this study we measured salivary endothelin-1 (ET-1) levels in patients diagnosed with oral squamous cell carcinoma (SCC) prior to treatment. We demonstrate significantly elevated salivary ET-1 levels in the oral SCC group (4.37 ± 1.35 pg/ml), relative to the control group (1.16 ± 0.29 pg/ml). ET-1 and ET-1 mRNA were also measured in oral SCC tissue specimens and compared to normal oral epithelial controls. The concentration of ET-1 in the oral SCC specimens was 17.87 ± 4.0 pg/ml and in the normal epithelial controls the concentration of ET-1 was 5.43 ± 2.5 pg/ml. ET-1 mRNA was significantly overexpressed in 80{\%} (8/10) of the oral SCC specimens. Our results demonstrate the potential utility of salivary analysis for ET-1 levels to monitor patients at risk for oral SCC.",
keywords = "Endothelin, ET-1, Oral cancer, Oral squamous cell carcinoma, Saliva",
author = "Victoria Pickering and Jordan, {Richard C K} and Brian Schmidt",
year = "2007",
month = "1",
doi = "10.1016/j.oraloncology.2005.12.027",
language = "English (US)",
volume = "43",
pages = "37--41",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Elevated salivary endothelin levels in oral cancer patients-A pilot study

AU - Pickering, Victoria

AU - Jordan, Richard C K

AU - Schmidt, Brian

PY - 2007/1

Y1 - 2007/1

N2 - The analysis of saliva has been proposed as a potentially rapid, non-invasive method to monitor and diagnose patients with oral disease. In this study we measured salivary endothelin-1 (ET-1) levels in patients diagnosed with oral squamous cell carcinoma (SCC) prior to treatment. We demonstrate significantly elevated salivary ET-1 levels in the oral SCC group (4.37 ± 1.35 pg/ml), relative to the control group (1.16 ± 0.29 pg/ml). ET-1 and ET-1 mRNA were also measured in oral SCC tissue specimens and compared to normal oral epithelial controls. The concentration of ET-1 in the oral SCC specimens was 17.87 ± 4.0 pg/ml and in the normal epithelial controls the concentration of ET-1 was 5.43 ± 2.5 pg/ml. ET-1 mRNA was significantly overexpressed in 80% (8/10) of the oral SCC specimens. Our results demonstrate the potential utility of salivary analysis for ET-1 levels to monitor patients at risk for oral SCC.

AB - The analysis of saliva has been proposed as a potentially rapid, non-invasive method to monitor and diagnose patients with oral disease. In this study we measured salivary endothelin-1 (ET-1) levels in patients diagnosed with oral squamous cell carcinoma (SCC) prior to treatment. We demonstrate significantly elevated salivary ET-1 levels in the oral SCC group (4.37 ± 1.35 pg/ml), relative to the control group (1.16 ± 0.29 pg/ml). ET-1 and ET-1 mRNA were also measured in oral SCC tissue specimens and compared to normal oral epithelial controls. The concentration of ET-1 in the oral SCC specimens was 17.87 ± 4.0 pg/ml and in the normal epithelial controls the concentration of ET-1 was 5.43 ± 2.5 pg/ml. ET-1 mRNA was significantly overexpressed in 80% (8/10) of the oral SCC specimens. Our results demonstrate the potential utility of salivary analysis for ET-1 levels to monitor patients at risk for oral SCC.

KW - Endothelin

KW - ET-1

KW - Oral cancer

KW - Oral squamous cell carcinoma

KW - Saliva

UR - http://www.scopus.com/inward/record.url?scp=33846476642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846476642&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2005.12.027

DO - 10.1016/j.oraloncology.2005.12.027

M3 - Article

VL - 43

SP - 37

EP - 41

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

IS - 1

ER -